Magnus Esbjörnsson
@magnusesbjornsson.bsky.social
Vascular neurologist, southern Sweden
Reposted by Magnus Esbjörnsson
1/ 🚨 The @ec.europa.eu must now take a stance on lecanemab. After months of delays and an inconclusive Appeal Committee outcome, patients with early Alzheimer’s disease are left in limbo. This has real-world consequences. 🧠🕰️
www.alzheimer-europe.org/news/after-a...
www.alzheimer-europe.org/news/after-a...
After Appeal Committee “no opinion” on lecanemab for the treatment of Alzheimer’s disease, final decision reverts to European Commission
On 14 April, the minutes of the Appeal Committee of 7 April were published (
www.alzheimer-europe.org
April 14, 2025 at 1:46 PM
1/ 🚨 The @ec.europa.eu must now take a stance on lecanemab. After months of delays and an inconclusive Appeal Committee outcome, patients with early Alzheimer’s disease are left in limbo. This has real-world consequences. 🧠🕰️
www.alzheimer-europe.org/news/after-a...
www.alzheimer-europe.org/news/after-a...
Reposted by Magnus Esbjörnsson
Cruel, destructive but presumably that’s the point. “Scientists studying neuroscience, diabetes, autism and bird flu became emotional as they spoke to the Guardian about the possibility of losing their life’s work.”
www.theguardian.com/us-news/2025...
www.theguardian.com/us-news/2025...
Trump cuts threaten a ‘generation of scientists’ as many weigh leaving US
President’s call to ‘Make America Healthy Again’ has led to slashes in NIH funding – endangering jobs and vital research
www.theguardian.com
February 19, 2025 at 10:16 PM
Cruel, destructive but presumably that’s the point. “Scientists studying neuroscience, diabetes, autism and bird flu became emotional as they spoke to the Guardian about the possibility of losing their life’s work.”
www.theguardian.com/us-news/2025...
www.theguardian.com/us-news/2025...
Important paper by Hall et al on the effects of comorbidities on the outcome of MeVOs treated with EVT www.ahajournals.org/doi/10.1161/...
Influence of Comorbidity on Endovascular Thrombectomy Outcomes for Medium‐Vessel Occlusion Stroke: A Nationwide Prospective Observational Study | Stroke: Vascular and Interventional Neurology
www.ahajournals.org
January 6, 2025 at 12:22 PM
Important paper by Hall et al on the effects of comorbidities on the outcome of MeVOs treated with EVT www.ahajournals.org/doi/10.1161/...
Reposted by Magnus Esbjörnsson
En ny svensk studie har undersökt svar på svenska allmänläkares specialisttentamen med Chat GPT (fritextsvar på komplicerade patientärenden). Allmänläkarna var betydligt bättre.
Fin bild från studien.
bmjopen.bmj.com/content/14/1...
Fin bild från studien.
bmjopen.bmj.com/content/14/1...
January 4, 2025 at 11:53 AM
En ny svensk studie har undersökt svar på svenska allmänläkares specialisttentamen med Chat GPT (fritextsvar på komplicerade patientärenden). Allmänläkarna var betydligt bättre.
Fin bild från studien.
bmjopen.bmj.com/content/14/1...
Fin bild från studien.
bmjopen.bmj.com/content/14/1...
Reposted by Magnus Esbjörnsson
Updates on FXIa inhibitors!
🩸 New study from Matthew Bunce reveals ways to reverse milvexian, a novel FXIa inhibitor.
🧪 Activated PCCs & rFVIIa can neutralize its anticoagulant effects in emergencies. www.rpthjournal.org/article/S247...
🩸 New study from Matthew Bunce reveals ways to reverse milvexian, a novel FXIa inhibitor.
🧪 Activated PCCs & rFVIIa can neutralize its anticoagulant effects in emergencies. www.rpthjournal.org/article/S247...
December 4, 2024 at 9:33 PM
Updates on FXIa inhibitors!
🩸 New study from Matthew Bunce reveals ways to reverse milvexian, a novel FXIa inhibitor.
🧪 Activated PCCs & rFVIIa can neutralize its anticoagulant effects in emergencies. www.rpthjournal.org/article/S247...
🩸 New study from Matthew Bunce reveals ways to reverse milvexian, a novel FXIa inhibitor.
🧪 Activated PCCs & rFVIIa can neutralize its anticoagulant effects in emergencies. www.rpthjournal.org/article/S247...
Reposted by Magnus Esbjörnsson
Reposted by Magnus Esbjörnsson
👋 Hey there, neuro peeps! Today we're diving headfirst into the whirlpool of vertigo! 😵💫
Ever felt like the world is spinning around you (and not just in the normal overwhelming way)? Let's unravel this dizzying mystery together!
Let’s gooo--owhooaah!--🌀🧠 #Blutorial #NeuroSky #MedSky
Ever felt like the world is spinning around you (and not just in the normal overwhelming way)? Let's unravel this dizzying mystery together!
Let’s gooo--owhooaah!--🌀🧠 #Blutorial #NeuroSky #MedSky
a movie poster for vertigo special edition with james stewart and kim novak
ALT: a movie poster for vertigo special edition with james stewart and kim novak
media.tenor.com
November 18, 2024 at 4:07 PM
👋 Hey there, neuro peeps! Today we're diving headfirst into the whirlpool of vertigo! 😵💫
Ever felt like the world is spinning around you (and not just in the normal overwhelming way)? Let's unravel this dizzying mystery together!
Let’s gooo--owhooaah!--🌀🧠 #Blutorial #NeuroSky #MedSky
Ever felt like the world is spinning around you (and not just in the normal overwhelming way)? Let's unravel this dizzying mystery together!
Let’s gooo--owhooaah!--🌀🧠 #Blutorial #NeuroSky #MedSky
Reposted by Magnus Esbjörnsson
🚨NEW POD ALERT🚨
Andexanet Alfa FDA Committee Meeting Recap 🩸
FDA v. AZ findings ⚔️
Applying ANNEXA-I results to other populations? 🧠
Hemostasis v. clinical outcomes ⚰️
Thromboembolic event breakdown 📈
Committee discussion points 🤔
& much, much more!
🍎 https://buff.ly/3VduBN4
Andexanet Alfa FDA Committee Meeting Recap 🩸
FDA v. AZ findings ⚔️
Applying ANNEXA-I results to other populations? 🧠
Hemostasis v. clinical outcomes ⚰️
Thromboembolic event breakdown 📈
Committee discussion points 🤔
& much, much more!
🍎 https://buff.ly/3VduBN4
November 28, 2024 at 1:42 AM
🚨NEW POD ALERT🚨
Andexanet Alfa FDA Committee Meeting Recap 🩸
FDA v. AZ findings ⚔️
Applying ANNEXA-I results to other populations? 🧠
Hemostasis v. clinical outcomes ⚰️
Thromboembolic event breakdown 📈
Committee discussion points 🤔
& much, much more!
🍎 https://buff.ly/3VduBN4
Andexanet Alfa FDA Committee Meeting Recap 🩸
FDA v. AZ findings ⚔️
Applying ANNEXA-I results to other populations? 🧠
Hemostasis v. clinical outcomes ⚰️
Thromboembolic event breakdown 📈
Committee discussion points 🤔
& much, much more!
🍎 https://buff.ly/3VduBN4
Reposted by Magnus Esbjörnsson
Observational study of 1100 patients… Anticoagulant-associated ICH less likely to be associated with CAA
www.ahajournals.org/doi/full/10....
www.ahajournals.org/doi/full/10....
American Heart Association Journals
www.ahajournals.org
November 27, 2024 at 2:45 PM
Observational study of 1100 patients… Anticoagulant-associated ICH less likely to be associated with CAA
www.ahajournals.org/doi/full/10....
www.ahajournals.org/doi/full/10....
Reposted by Magnus Esbjörnsson
Agreed… and when you look at the timing of those TEs hard to convince me that Andexxa isn’t exacerbating the risk
November 21, 2024 at 6:03 PM
Agreed… and when you look at the timing of those TEs hard to convince me that Andexxa isn’t exacerbating the risk
Reposted by Magnus Esbjörnsson
